Neuberger Berman Group »

Atyr Pharma shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $16k 21k 0.78

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jan28 Now P @ 120.000000 Option Put Option (NOW)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
February 26 Calls on HD US Option Call Option (HD)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Ishares Core S&p 500 Etf Etf (IVV)
Nextera Energy Common (NEE)
Visa Inc-class A Shares Common (V)

View all positions for Neuberger Berman Group

Top funds holding Atyr Pharma

FMR
Federated Investors
BlackRock
Vanguard Group
GSA Capital Partners
Geode Capital Management
Millennium Management
State Street Corporation
UBS Group
Susquehanna International
Rosalind Advisors
Citadel Advisors
Northern Trust
Jane Street
Balyasny Asset Management

View all funds holding Atyr Pharma